FGNCX | VCRIX | FGNCX / VCRIX | |
Total Expense Ratio | 1.96 | 0.97 | 202% |
Annual Report Gross Expense Ratio | 2.09 | 1.03 | 203% |
Fund Existence | 17 years | 12 years | - |
Gain YTD | 14.092 | 12.990 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 484M | 1.17B | 41% |
Annual Yield % from dividends | 1.34 | 2.06 | 65% |
Returns for 1 year | 13.74 | 16.09 | 85% |
Returns for 3 years | 11.92 | 15.15 | 79% |
Returns for 5 years | 28.49 | 40.77 | 70% |
Returns for 10 years | 31.27 | 57.84 | 54% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 43.63 | 0.46 | +1.07% |
SPDR® S&P Pharmaceuticals ETF | |||
SSUS | 45.71 | -0.13 | -0.28% |
Day Hagan Smart Sector ETF | |||
INRO | 29.95 | -0.10 | -0.32% |
iShares U.S. Industry Rotation Act ETF | |||
SGOL | 31.96 | -0.46 | -1.42% |
abrdn Physical Gold Shares ETF | |||
CONI | 2.53 | -0.15 | -5.60% |
GraniteShares 2x Short COIN Daily ETF |